ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum Folic Acid Levels in Preterm Infants (FALIPI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01360528
Recruitment Status : Completed
First Posted : May 25, 2011
Last Update Posted : February 17, 2012
Sponsor:
Information provided by (Responsible Party):
Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Therefore preterm infants must need folic acid replacement than term babies.

Condition or disease
Very Low Birth Weight Baby

Detailed Description:
All babies need to different vitamin supplementation. Especially preterm infants need some vitamin supplements. Folic acid is very important structure of part of cell growing.ın theorically; preterm infants have very rapid cell reproduction capacity than term infants. Therefore preterm infants must need folic acid replacement than term babies. The investigators want to determine preterm infants folic acid levels due to gestational age whether needs folic acid replacement.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Zekai Tahir Burak Maternity and Teaching Hospital
Study Start Date : February 2011
Actual Primary Completion Date : May 2011
Actual Study Completion Date : October 2011

Resource links provided by the National Library of Medicine

Drug Information available for: Folic acid
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Extremely low birth weight
Extremely low birth weight under 1000 gram
Very low birth weight
Between 1000-1500 gram babies
Low birth weight
Between 1500-2500 gram


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   24 Weeks to 34 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Extremely low birth weight, Very low birth weight, Low birth weight
Criteria

Inclusion Criteria:

-All preterm infants

Exclusion Criteria:

-Major congenital anomaly

Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01360528


Locations
Turkey
Zekai Tahir Burak Maternity Teaching Hospital, Neonatology Unit
Ankara, Turkey, 06600
Sponsors and Collaborators
Mehmet Yekta
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital
ClinicalTrials.gov Identifier: NCT01360528     History of Changes
Other Study ID Numbers: ztb5326315185
First Posted: May 25, 2011    Key Record Dates
Last Update Posted: February 17, 2012
Last Verified: February 2011

Keywords provided by Mehmet Yekta, Zekai Tahir Burak Maternity and Teaching Hospital:
Folic acid replacement
Folic acid
Preterm neonate

Additional relevant MeSH terms:
Birth Weight
Body Weight
Signs and Symptoms
Folic Acid
Vitamin B Complex
 Hematinics
Vitamins
Micronutrients
Growth Substances
Physiological Effects of Drugs